Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Investor conferences - seeking investors for clincal phase IIb funding

Reference number
Coordinator Stayble Therapeutics AB
Funding from Vinnova SEK 15 000
Project duration February 2019 - February 2019
Status Completed

Purpose and goal

The goal with the project is to by attending two investor meeting identify potential new investors that would be interested in investing in Stayble´s up-coming investment round.

Expected results and effects

The expected result is to connect with new investors relevant for the next investment round.

Planned approach and implementation

Participation at tw o investor congresses: - LSX W orld Congress (London, 5-6/2 2019) - Sw iss Nordic Bio (Zürich, 7/2 2019)

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 15 February 2019

Reference number 2019-01096

Page statistics